Stephen V Liu, Director of Thoracic Oncology, Chief of the Division of Hematology and Oncology, and Associate Professor at Georgetown Lombardi Comprehensive Cancer Center, shared a post on shared a post on X:
“Report JCO Oncology Practice: in 371 pts with no brain metastases, 26% developed metastases over 3 years. Brain was first site of progression in 18% and only site in 11%.
1 year incidence similar with chemo and with chemo-IO. PCI lowers risk. Will bispecifics/ADCs improve risk?”
Title: Incidence, Risk Factors, and Impact of Immunotherapy on Brain Metastasis in Extensive-Stage Small Cell Lung Cancer Without Baseline Brain Involvement
Authors: Wenli Cao, Xiangjuan Ma, Weiheng Hu, Furong Kou, Yanfei Liu, Jun Nie, Ling Dai, Jie Zhang, Jian Fang, Yang Wang
Other articles featuring Stephen V Liu on OncoDaily.